Potent PCSK9 Inhibitors
Thomas explains how PCSK9 inhibitors significantly lower ApoB levels by extending the lifespan of LDL receptors, leading to enhanced clearance of LDL particles. The inhibitors are crucial for patients with familial hypercholesterolemia and acute coronary syndrome, revolutionizing the standard of care for heart attack survivors.In this clip
From this podcast
The Proof with Simon Hill
Preventing and treating cardiovascular disease (Lipid Series - Part 3) | Dr Thomas Dayspring
Related Questions